R&D | January 28, 2026
Eastman & Kolmar Korea join forces to deliver biodegradable beauty breakthroughs
The collaboration will center on expanding access to Eastman’s Esmeri technology
The collaboration will center on expanding access to Eastman’s Esmeri technology
A dedicated Life Sciences Innovation Fund, scalable up to Rs. 1,000 crore, will catalyze early- and growth-stage innovation, support deep-tech ventures – particularly biotherapeutics
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
BBIL will guarantee production and supply of MTBVAC to more than 70 countries across Africa and Southeast Asia
The new site will produce next-generation synthetic medicine active pharmaceutical ingredients
Expands bioprocessing footprint across Asia
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
Speakers are: Ch. A. P. Rameswara Rao, National President, BDMAI; Dr. Paidi Yella Reddy, Founder, President & CEO, Sapala Organics; K. V. Rama Gopal, Site Manager & Executive Director, Clariant India; Dr. K. Nagaiah, Chief Scientist, CSIR - Indian Institute of Chemical Technology, Hyderabad; Dr. Satyanarayana Thirunahari, Senior General Manager - Process Safety & Engineering, Laurus Labs; and Yadavendra Shalgaonkar, Assistant General Manager - Tube Sales, Alleima India
Sessions will cover process mapping, cost optimisation, data-driven decision-making, cybersecurity, and sustainable manufacturing practices
It will focus on interface between API and formulation manufacturing, reducing carbon footprint in formulation production, creating intellectual property, training next-generation scientists, and setting new industry benchmarks
Subscribe To Our Newsletter & Stay Updated
